---
title: "Pre-market hot trades in US stocks: Chubb pre-market down 3.80%; AMD pre-market down 3.28%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293474665.md"
description: "Chubb pre-market down 3.80%; AMD pre-market down 3.28%; Lakewood-Amedex Biotherapeutics pre-market up 236.56%; Inlif pre-market up 45.28%; Core AI pre-market up 40.72%"
datetime: "2026-07-22T12:37:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293474665.md)
  - [en](https://longbridge.com/en/news/293474665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293474665.md)
---

# Pre-market hot trades in US stocks: Chubb pre-market down 3.80%; AMD pre-market down 3.28%

**Pre-market Hot Trades in US Stocks**

Chubb pre-market down 3.80%. Based on recent news,

1.  On July 21, Chubb released its second-quarter financial report, showing core operating income of $7.26 per share, exceeding analysts' expectations of $6.75. Net premium income grew 3.6% year-on-year to $14.71 billion, with net premium income increasing from $13.13 billion to $13.89 billion. Strong financial data drove stock price fluctuations.
    
2.  On July 21, Chubb's property and casualty insurance sector reported a combined ratio of 83.8%, an improvement from 85.6% in the same period last year. This indicates the company's strong performance in premium income, further impacting the stock price.
    
3.  On July 15, Piper Sandler analyst Paul Newsome maintained a neutral rating and raised the target price from $340 to $374. Several analysts raised their target prices, reflecting market confidence in Chubb's future performance. The insurance industry has performed strongly recently, and investors should pay attention to market volatility risks.
    

AMD pre-market down 3.28%. Based on recent key news:

1.  On July 22, GF Securities reported that AMD's upcoming "Advancing AI 2026" conference may bring positive news, including new customers and product launches, driving expectations for a stock price increase. Source: Zhitong Finance
    
2.  On July 21, AMD partnered with Microsoft, with Azure set to deploy AMD Helios rack-level solutions on a large scale, pushing the stock price up 8.11%. Source: MoneyDJ
    
3.  On July 20, Ark Invest reduced its holdings in AMD stock, selling a total of 137,421 shares in July, affecting stock price fluctuations. Source: TMT Post. The chip industry demand is strong, and market volatility is evident.
    

**Top Gainers in Pre-market US Stocks**

Lakewood-Amedex pre-market up 236.56%. Based on recent key news:

1.  On July 22, Lakewood-Amedex released new resistance data regarding its Nu-3 candidate drug. Nu-3 did not show induced resistance in continuous passage studies, supporting its membrane-disrupting mechanism and positioning it in antibiotic resistance development. This news significantly boosted the stock price.
    
2.  On July 22, the company stated that clinical trials may not start, complete, or succeed as expected, and product candidates may not prove safety or efficacy. These risk factors may affect investor confidence.
    
3.  On July 22, Lakewood-Amedex's press release emphasized the potential uncertainties in its product development, including risks related to manufacturing, supply, and financing, which may lead to market concerns about the company's future development. The biotechnology industry has been volatile recently, requiring attention Inlif pre-market rose 45.28%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
    

Core AI pre-market rose 40.72%. Based on recent key news:

1.  On July 21, Core AI announced the expansion of its AI strategy, launching a multimodal home design and renovation visualization tool. This strategic move aims to enhance the company's service capabilities and solidify its position in the industry. This involves significant investment and is expected to expand the company's market coverage.
    
2.  On July 21, Core AI's low price-to-earnings ratio provides some valuation support, but it is not enough to offset financial and trend risks. Nevertheless, the market's increased attention to its AI technology and infrastructure has driven the stock price up.
    
3.  On July 21, Core AI detailed risk factors in its annual report, including market conditions, customer demand, and supply chain status, which may lead to significant differences between actual results and expectations. Despite these risks, investors remain optimistic about its future growth potential. The acceleration of innovation in the AI industry has increased market attention

### Related Stocks

- [CB.US](https://longbridge.com/en/quote/CB.US.md)
- [AMD.US](https://longbridge.com/en/quote/AMD.US.md)
- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)
- [INLF.US](https://longbridge.com/en/quote/INLF.US.md)
- [CHAI.US](https://longbridge.com/en/quote/CHAI.US.md)

## Related News & Research

- [CORZ Stock Alert: Core Scientific Strikes AI Infrastructure Deal With AMD](https://longbridge.com/en/news/294105050.md)
- [CBRS Stock Alert: What to Know as Cerebras Teams Up With AMD](https://longbridge.com/en/news/293768646.md)
- [AMD stock sets up for this bearish trade as AI bubble trouble looms](https://longbridge.com/en/news/294079975.md)
- [Dear AMD Stock Fans, Mark Your Calendars for August 4](https://longbridge.com/en/news/294256558.md)
- [What a Major Anthropic Chip Deal Really Means for AMD Stock](https://longbridge.com/en/news/293846559.md)